Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model".

BACKGROUND The mathematical models for patients with diabetes proposed in the literature since the late 1970s are mainly glucocentric (glucose-based); hence, the contribution of free fatty acid (FFA) metabolism in the body and its glucose-insulin interactions have been largely ignored. However, approximately 90% of the muscle energy is derived from FFA metabolism when the body is at rest. Furthermore, significant interactions exist among FFA, glucose, and insulin. With the long-term goal of developing a closed-loop glucose control system, a model of the major energy-providing substrate dynamics is required. METHODS The Bergman minimal model was extended to include plasma FFA dynamics, and its interaction with glucose and insulin dynamics, with a primary focus on patients with Type 1 diabetes. Differential equations were developed for plasma FFA concentrations and "remote" FFA effects on glucose uptake, as well as "remote" insulin effects on plasma FFA concentrations. Parameters for the model were estimated from experimental data provided in the scientific literature. RESULTS The minimal model was extended in order to capture three major metabolic aspects: the antilipolytic effect of insulin; the lipolytic effect of prolonged hyperglycemia; and the impairing effect of FFA on glucose uptake rate. The dynamic fit of glucose, FFA, and insulin profiles is consistent with published data. CONCLUSIONS The extended minimal model successfully captured the plasma FFA concentration behavior, the plasma insulin and glucose concentrations, and the physiological interactions that exist among these species. This more comprehensive description of energy-providing substrate dynamics may provide a novel simulation test-bed for analysis of patients with insulin dependent diabetes and controller design.

[1]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[2]  C Cobelli,et al.  Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. , 1986, The American journal of physiology.

[3]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[4]  Francis J. Doyle,et al.  Glucose control design using nonlinearity assessment techniques , 2005 .

[5]  B.W. Bequette,et al.  Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements , 2002, Proceedings of the 2002 American Control Conference (IEEE Cat. No.CH37301).

[6]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[7]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[8]  Evanghelos Zafiriou,et al.  Robust process control , 1987 .

[9]  M. Vranic,et al.  Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. , 2002, Diabetes.

[10]  H. Akaike.  A Bayesian extension of the minimum AIC procedure of autoregressive model fitting , 1979 .

[11]  R. DeFronzo,et al.  Effect of long chain triglyceride infusion on glucose metabolism in man. , 1982, Metabolism: clinical and experimental.

[12]  V. Mougios,et al.  Exercise-induced changes in the concentration of individual fatty acids and triacylglycerols of human plasma. , 1995, Metabolism: clinical and experimental.

[13]  Robert S. Parker,et al.  Empirical Modeling for Glucose Control in Critical Care and Diabetes , 2005, Eur. J. Control.

[14]  A. Goldberg,et al.  Time course of plasma free fatty acid concentration in response to insulin: effect of obesity and physical fitness. , 1992, Metabolism: clinical and experimental.

[15]  K. Frayn,et al.  Non-esterified fatty acid metabolism and postprandial lipaemia. , 1998, Atherosclerosis.

[16]  A. Green,et al.  Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose. , 1999, Diabetes.

[17]  R. Downs,et al.  Potentiation by Glucose of Lipolytic Responsiveness of Human Adipocytes , 1986, Diabetes.

[18]  Claudio Cobelli,et al.  Minimal model SGoverestimation and SIunderestimation: improved accuracy by a Bayesian two-compartment model. , 1999, American journal of physiology. Endocrinology and metabolism.

[19]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[20]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[21]  B. Howard,et al.  The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. , 1984, The Journal of clinical endocrinology and metabolism.

[22]  P. Felig,et al.  Fuel homeostasis in exercise. , 1975, The New England journal of medicine.

[23]  T. Szkudelski,et al.  Glucose as a lipolytic agent: studies on isolated rat adipocytes. , 2000, Physiological Research.

[24]  I. Godsland,et al.  Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. , 1994, Metabolism: clinical and experimental.

[25]  V. R. Kondepati,et al.  Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients , 2007, Analytical and bioanalytical chemistry.